Search

everythinglearnresearchcommunity

for

Search:↓

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Alpha mangostin may protect certain breast cancer cells by activating the p53 pathway.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Prostaglandins may protect hair follicles during chemotherapy.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Procyanidins may have antioxidant, heart health, cancer-fighting, anti-inflammatory, anti-diabetic, liver-protective, and other health benefits with high efficiency and low toxicity.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Better awareness of chemotherapy's side effects improves self-care.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Pesticides can cause reproductive and adrenal health issues.

Early detection of chemotherapy side effects allows treatment adjustments, improving patient outcomes.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Combining scalp cooling with a special lotion helps prevent severe hair loss in breast cancer patients undergoing chemotherapy.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Selenium supplements do not prevent cancer and may have harmful effects.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.